India's Zydus Cadila Launches Cancer Drug Nudoxa
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Ahmedabad, India-based Zydus Cadila said it will begin manufacturing and marketing cancer treatment Nudoxa, with patents in India and South Africa for a gentler variant of liposomal doxorubicin that mitigates side effects such as skin eruptions on the hands and feet